BMC Gastroenterol

1. CHEN J, Zhou W, Chen C, Mi F, et al
   Global prevalence of chronic kidney disease and its influencing factors among chronic hepatitis B: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:725.
   

   >> Share

   
   
2. ZHAO J, Cheng J, Liang S, Guo W, et al
   Aberrant alternative splicing in alcoholic hepatitis: regulatory roles of RBPs and sQTLs.
   BMC Gastroenterol. 2025;25:728.
   

   >> Share

   
   

   
   Hepatology

3. SIDHU G
   When "remission" isn't enough: The unseen burden of autoimmune hepatitis.
   Hepatology. 2025;82:1037-1038.
   

   >> Share

   
   
4. DANPANICHKUL P, Duangsonk K, Chen VL, Saokhieo P, et al
   Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.
   Hepatology. 2025;82:1274-1286.
   

   >> Share

   
   
5. YOUNOSSI ZM, de Avila L, Racila A, Nader F, et al
   Prevalence and predictors of cirrhosis and portal hypertension in the united states.
   Hepatology. 2025 Jan 29. doi: 10.1097/HEP.0000000000001243.
   

   >> Share

   
   

   
   J Hepatol

6. POLAT M, Wahlin S, Efe C
   Can Autoimmune Hepatitis be diagnosed and treated without liver biopsy?
   J Hepatol. 2025 Oct 10:S0168-8278(25)02552-8. doi: 10.1016/j.jhep.2025.
   

   >> Share

   
   

   
   J Infect Dis

7. CHEN J, Huang Z, Yang X, Yang Y, et al
   Predictors of Durable Hepatitis B Surface Antigen Loss After Pegylated Interferon-Based Therapy in Patients with Hepatitis B e Antigen-Negative Chronic Hepatitis B: A Multicenter Real-World Study.
   J Infect Dis. 2025;232:953-960.
   

   >> Share

   
   
8. DAWES BE, De La Mota-Peynado A, Rezende IM, Buyukcangaz EK, et al
   Rift Valley Fever Virus Infectivity in Milk Stored at a Wide Range of Temperatures.
   J Infect Dis. 2025;232:e661-e670.
   

   >> Share

   
   

   
   J Med Virol

9. ABRESCIA N, Maddaloni A, D'Abbraccio M, Molinaro G, et al
   Hepatitis B Control in Italy: The 35-Year Impact of Universal Infant Vaccination and Lessons for Global Elimination.
   J Med Virol. 2025;97:e70646.
   

   >> Share

   
   

   
   J Viral Hepat

10. BADIA L, Ciancio A, Distefano M, Izzi A, et al
    Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study.
    J Viral Hepat. 2025;32:e70097.
    

    >> Share

    
    
11. XIE T, Su M, Cai M, Zhao T, et al
    Real-World Study for Mother-To-Child Transmission of Hepatitis B in Guangdong Province, 2021-2023.
    J Viral Hepat. 2025;32:e70094.
    

    >> Share

    
    
12. HARDIE DR, Korsman SNJ, Valley-Omar Z, Petersen N, et al
    Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa.
    J Viral Hepat. 2025;32:e70095.
    

    >> Share

    
    
13. OLTMANNS C, Witte M, Wranke A, Deterding K, et al
    HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.
    J Viral Hepat. 2025;32:e70092.
    

    >> Share

    
    
14. GRANTZ KH, Cummings DAT, Romero LM, Astemborski J, et al
    Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling Study.
    J Viral Hepat. 2025;32:e70096.
    

    >> Share

    
    

    
    J Virol

15. YU X, Liu C-D, Shen S, Kim ES, et al
    Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPalpha.
    J Virol. 2025 Oct 13:e0150925. doi: 10.1128/jvi.01509.
    

    >> Share

    
    

    
    PLoS One

16. CHIVITE I, Guilera V, Callau P, Aguilo R, et al
    Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain.
    PLoS One. 2025;20:e0328464.
    

    >> Share

    
    
17. MA X, Bai R, Zhu Z, Wang T, et al
    Hepatotoxicity risk factors in HIV-infected MSM with HBV/HCV coinfections: A cohort study in Northwestern China.
    PLoS One. 2025;20:e0333371.
    

    >> Share

    
    

    
    Vaccine

18. RACCAGNI AR, Morsica G, Reali P, Lolatto R, et al
    Long-term protection and response to a booster dose after primary hepatitis B vaccination in people under pre-exposure prophylaxis for HIV infection.
    Vaccine. 2025;66:127825.
    

    >> Share

    
    
19. COLLINS C, Ratshisusu L, Modise LM, Simani OE, et al
    Hepatitis B virus infection and vaccine coverage among children living with HIV, HIV-exposed uninfected, and HIV-unexposed uninfected children in the Western Cape, South Africa.
    Vaccine. 2025;66:127843.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share